BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 12598410)

  • 21. Evidence for a direct interaction between the Thr11 residue of vasoactive intestinal polypeptide and Tyr184 located in the first extracellular loop of the VPAC2 receptor.
    Nachtergael I; Vertongen P; Langer I; Perret J; Robberecht P; Waelbroeck M
    Biochem J; 2003 Mar; 370(Pt 3):1003-9. PubMed ID: 12475394
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple signal pathways coupling VIP and PACAP receptors to calcium channels in hamster submandibular ganglion neurons.
    Kamaishi H; Endoh T; Suzuki T
    Auton Neurosci; 2004 Mar; 111(1):15-26. PubMed ID: 15109935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.
    Goursaud S; Pineau N; Becq-Giraudon L; Gressens P; Muller JM; Janet T
    J Neuroimmunol; 2005 Jan; 158(1-2):94-105. PubMed ID: 15589042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gamma-Aminobutyric acid (GABA) transport across human intestinal epithelial (Caco-2) cell monolayers.
    Thwaites DT; Basterfield L; McCleave PM; Carter SM; Simmons NL
    Br J Pharmacol; 2000 Feb; 129(3):457-64. PubMed ID: 10711343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interactions of a nonpeptidic drug, valacyclovir, with the human intestinal peptide transporter (hPEPT1) expressed in a mammalian cell line.
    Guo A; Hu P; Balimane PV; Leibach FH; Sinko PJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):448-54. PubMed ID: 10087037
    [TBL] [Abstract][Full Text] [Related]  

  • 27. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
    Thwaites DT; Brown CD; Hirst BH; Simmons NL
    Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor subtypes in human tumors and their tissues of origin.
    Reubi JC; Läderach U; Waser B; Gebbers JO; Robberecht P; Laissue JA
    Cancer Res; 2000 Jun; 60(11):3105-12. PubMed ID: 10850463
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VIP enhances synaptic transmission to hippocampal CA1 pyramidal cells through activation of both VPAC1 and VPAC2 receptors.
    Cunha-Reis D; Ribeiro JA; Sebastião AM
    Brain Res; 2005 Jul; 1049(1):52-60. PubMed ID: 15935995
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneity of neuronal and smooth muscle receptors involved in the VIP- and PACAP-induced relaxations of the pig intravesical ureter.
    Hernández M; Barahona MV; Recio P; Rivera L; Benedito S; Martínez AC; García-Sacristán A; Orensanz LM; Prieto D
    Br J Pharmacol; 2004 Jan; 141(1):123-31. PubMed ID: 14662737
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
    Thwaites DT; Hirst BH; Simmons NL
    Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland.
    Mazzocchi G; Malendowicz LK; Neri G; Andreis PG; Ziolkowska A; Gottardo L; Nowak KW; Nussdorfer GG
    Int J Mol Med; 2002 Mar; 9(3):233-43. PubMed ID: 11836629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
    Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
    Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Distribution of vasoactive intestinal peptide, pituitary adenylate cyclase-activating peptide, nitric oxide synthase, and their receptors in human and rat sphenopalatine ganglion.
    Csati A; Tajti J; Kuris A; Tuka B; Edvinsson L; Warfvinge K
    Neuroscience; 2012 Jan; 202():158-68. PubMed ID: 22108610
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The apical (hPepT1) and basolateral peptide transport systems of Caco-2 cells are regulated by AMP-activated protein kinase.
    Pieri M; Christian HC; Wilkins RJ; Boyd CA; Meredith D
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G136-43. PubMed ID: 20430871
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological characterization and expression of VIP and PACAP receptors in isolated cranial arteries of the rat.
    Baun M; Hay-Schmidt A; Edvinsson L; Olesen J; Jansen-Olesen I
    Eur J Pharmacol; 2011 Nov; 670(1):186-94. PubMed ID: 21914446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vigabatrin transport across the human intestinal epithelial (Caco-2) brush-border membrane is via the H+ -coupled amino-acid transporter hPAT1.
    Abbot EL; Grenade DS; Kennedy DJ; Gatfield KM; Thwaites DT
    Br J Pharmacol; 2006 Feb; 147(3):298-306. PubMed ID: 16331283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The human vasoactive intestinal peptide/pituitary adenylate cyclase-activating peptide receptor 1 (VPAC1) promoter: characterization and role in receptor expression during enterocytic differentiation of the colon cancer cell line Caco-2Cl.20.
    Couvineau A; Maoret JJ; Rouyer-Fessard C; Carrero I; Laburthe M
    Biochem J; 2000 May; 347 Pt 3(Pt 3):623-32. PubMed ID: 10769164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A lymphocyte-generated fragment of vasoactive intestinal peptide with VPAC1 agonist activity and VPAC2 antagonist effects.
    Summers MA; O'Dorisio MS; Cox MO; Lara-Marquez M; Goetzl EJ
    J Pharmacol Exp Ther; 2003 Aug; 306(2):638-45. PubMed ID: 12750439
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gene ablation for PEPT1 in mice abolishes the effects of dipeptides on small intestinal fluid absorption, short-circuit current, and intracellular pH.
    Chen M; Singh A; Xiao F; Dringenberg U; Wang J; Engelhardt R; Yeruva S; Rubio-Aliaga I; Nässl AM; Kottra G; Daniel H; Seidler U
    Am J Physiol Gastrointest Liver Physiol; 2010 Jul; 299(1):G265-74. PubMed ID: 20430876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.